Studies have demonstrated that inhibiting SREBP‐1 mRNA expression reduces cholesterol levels, alleviates hepatic steatosis, and improves adipose tissue hypertrophy, obesity, and insulin resistance. This evidence concerns the gene SREBF1 and Obesity.